On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Heparin-Induced Thrombocytopenia and Thrombosis

TopicLeading institutions, researchers & key papers

Heparin-Induced Thrombocytopenia and Thrombosis is a topic indexed in ScholarIQ from OpenAlex.

What is known about Heparin-Induced Thrombocytopenia and Thrombosis?

ScholarIQrecord summary

This cluster of papers focuses on the phenomenon of Heparin-Induced Thrombocytopenia (HIT) and its associated thrombotic complications, particularly in the context of vaccination. The papers cover various aspects including pathogenesis, diagnosis, management, immune response, and the role of anticoagulation therapy in HIT. Additionally, they explore the clinical features and outcomes related to HIT and thrombosis.

How many works does Heparin-Induced Thrombocytopenia and Thrombosis have?

ScholarIQindexed works

Heparin-Induced Thrombocytopenia and Thrombosis has 130 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Heparin-Induced Thrombocytopenia and Thrombosis?

ScholarIQopenalex

The OpenAlex for Heparin-Induced Thrombocytopenia and Thrombosis is on the source record.

What are the most-cited papers on Heparin-Induced Thrombocytopenia and Thrombosis?

ScholarIQmost cited works
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Adam Cuker, Gowthami M. Arepally, Beng H. Chong, Douglas B. Cines, Andreas Greinacher, Yves Gruel, Lori Ann Linkins, Stephen B. Rodner, Sixten Selleng, Theodore E. Warkentin, Ashleigh Wex, Reem A. Mustafa, Rebecca L. Morgan, Nancy Santesso
Blood Advances. 2018736 CitationsOPEN ACCESS
Thrombocytopenia and prognosis in intensive care
Steven Vanderschueren, Annick De Weerdt, Manu L. N. G. Malbrain, D Vankersschaever, Eric Frans, Alexander Wilmer, Herman Bobbaers
Critical Care Medicine. 2000597 Citations
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
Colin R Simpson, Ting Shi, Eleftheria Vasileiou, Srinivasa Vittal Katikireddi, Stephen J. Kerr, Emily Moore, Colin McCowan, Utkarsh Agrawal, Syed Ahmar Shah, Lewis Ritchie, Josie Murray, Jiafeng Pan, Declan Bradley, Sarah J. Stock, Rachael Wood, Antony Chuter, Jillian Beggs, Helen R. Stagg, Mark Joy, Ruby S. M. Tsang, Simon de Lusignan, Richard Hobbs, Ronan A Lyons, Fatemeh Torabi, Stuart Bedston, Michael P. O’Leary, Ashley Akbari, Jim McMenamin, Chris Robertson, Aziz Sheikh
Nature Medicine. 2021263 CitationsOPEN ACCESS
Heparin-Induced Thrombocytopenia
Benjamin Salter, Menachem M. Weiner, Muoi Trinh, J Heller, Adam S. Evans, David Adams, Gregory W. Fischer
Journal of the American College of Cardiology. 2016213 CitationsOPEN ACCESS
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
Andreas Greinacher, Kathleen Selleng, Julia Mayerle, Raghavendra Palankar, Jan Wesche, Sven Reiche, Andrea Aebischer, Theodore E. Warkentin, Maximilian Muenchhoff, Johannes C. Hellmuth, Oliver T. Keppler, Daniel Duerschmied, Achim Lother, Siegbert Rieg, Meinrad Gawaz, Karin Anne Lydia Mueller, Christian Scheer, Matthias Napp, Klaus Hahnenkamp, Guglielmo Lucchese, Antje Vogelgesang, Agnes Flöel, Piero Lovreglio, Angela Stufano, Rolf Marschalek, Thomas Thiele, for the Immune-Response in COVID-19 Vaccination Study Group
Blood. 2021127 CitationsOPEN ACCESS

Where is Heparin-Induced Thrombocytopenia and Thrombosis research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Heparin-Induced Thrombocytopenia and Thrombosis is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
33%
Green
7%
Hybrid
7%
Bronze
20%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial